A new screening tool to measure quality of life in acne inversa (hidradenitis suppurativa) patients - 22/08/19
Lucia Tomas-Aragones, PhD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Servando E. Marron, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Rosa M. Diaz-Diaz, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Victor M. Alcalde-Herrero, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Francisco J. Garcia-Latasa de Aranibar, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Yolanda Gilaberte-Calzada, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Eva Vilarrasa-Rull, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Maria L. Zubiri-Ara, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Ana M. Morales-Callaghan, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain, Maria V. Fuentelsaz-del-Barrio, MD, Aragon Psychodermatology Research Group, Dermatology Department, Royo Villanova Hospital, Zaragoza, Spain
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB7 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?